STAA Q3 2022 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q3 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$76M+30.3% YoY

Gross Profit

$60M79.5% margin

Operating Income

$14M18.0% margin

Net Income

$10M13.5% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

-6.2%

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$395M

Total Liabilities

$75M

Stockholders' Equity

$320M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$58M	+30.3%
Gross Profit	$60M	$45M	+33.5%
Operating Income	$14M	$8M	+74.9%
Net Income	$10M	$6M	+70.5%

Revenue Segments

Implantable Collamer Lenses

$72M95%

Cataract Intraocular Lenses

$2M3%

Other Surgical Products

$2M3%